Cite
HARVARD Citation
Bruzzese, E. et al. (2018). Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome. Expert opinion on drug metabolism and toxicology. pp. 753-760. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bruzzese, E. et al. (2018). Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome. Expert opinion on drug metabolism and toxicology. pp. 753-760. [Online].